<DOC>
	<DOC>NCT02094911</DOC>
	<brief_summary>The overall aim of the project is to evaluate the (cost-)effectiveness of the SLIMMER diabetes prevention intervention in Dutch primary health care.</brief_summary>
	<brief_title>(Cost-)Effectiveness of SLIMMER Diabetes Prevention Intervention</brief_title>
	<detailed_description>This is a randomised controlled trial, conducted in a real-life setting (Dutch primary health care).</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Age 4070 years Impaired fasting glucose (IFG; i.e. venous plasma glucose concentration ≥6.1 and ≤6.9 mmol/l) during the past 5 years, according to the GP registration database OR diabetes risk score ≥7 as calculated from the Diabetes Risk Test Willing and able to participate in the intervention for at least 1.5 years Dutch speaking Known diabetes mellitus Any chronic illness that makes 1.5years survival improbable, interferes with glucose tolerance, or makes participation in a lifestyle intervention impossible Patients with any severe cardiovascular disease (this also includes history of cardiac dysrhythmia), unless GP gives agreement Medication known to interfere with glucose tolerance Any mental or physical disability that will hinder participation in the lifestyle intervention Severe psychiatric disease Patients who showed bad compliance in the past Participation in another regular vigorous exercise and/or diet programme, i.e.: Intensive exercise programme: any exercise programme offered by a physiotherapist and/or patients sporting at least 3 times a week at their own initiative. Intensive diet programme: patients who visited a dietician at least 3 times during the last year.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Prevention</keyword>
	<keyword>Combined lifestyle intervention</keyword>
	<keyword>Primary health care</keyword>
</DOC>